Discover 1,397 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,397
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
for
Arrhythmogenic Right Ventricular Cardiomyopathy
Location: Cleveland OH, Baltimore MD, New York NY, Boston MA,
Sponsor: Tenaya Therapeutics
Sex: All
Age: 18 - 65
Code: NCT06228924
Phase1, Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Cleveland OH, Royal Oak MI, Troy MI, Gahanna OH,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase2, Recruiting
Genetics of Uveitis
for
Uveitis, Infectious Uveitis
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 6+
Code: NCT02357238
Recruiting
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
for
Advanced/Metastatic Solid Tumors
Location: Cleveland OH, Houston TX, Scottsdale AZ, Seattle WA,
Sponsor: Adagene Inc
Sex: All
Age: 18+
Code: NCT05405595
Phase1, Phase2, Recruiting
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
for
Supratentorial Hemorrhage
Location: Cleveland OH, Buffalo NY, Hershey PA, Chicago IL,
Sponsor: Integra LifeSciences Corporation
Sex: All
Age: 18+
Code: NCT04494295
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Cooperative Huntington's Observational Research Trial
A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
for
Autosomal Recessive Polycystic Kidney (ARPKD)
Location: Cleveland OH, Ann Arbor MI, Cincinnati OH,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 0 - 18
Code: NCT04782258
Phase3, Recruiting
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass
Location: Cleveland OH, London, Ann Arbor MI, Kitchener, Hamilton,
Sponsor: Population Health Research Institute
Sex: All
Age: 18+
Code: NCT05701358
Recruiting
Tocilizumab in Lung Transplantation
for
Lung Transplant
Location: Cleveland OH, Columbus OH, New York NY, Durham NC,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 12 - 70+
Code: NCT06033196
Phase2, Recruiting
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
for
Cystic Fibrosis, CFTR Gene Mutation
Location: Cleveland OH, Nashville TN, St Louis MO, Boston MA,
Sponsor: Arcturus Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06747858
Phase2, Recruiting
Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)
for
Healthy
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18 - 65
Code: NCT05628974
Recruiting
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
for
Myositis
Location: Cleveland OH, Pittsburgh PA, New York NY, Boston MA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT05895786
Phase3, Recruiting
Patient Reported Outcome Instruments in Sarcoidosis